UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$577.34−6.76 (-1.16%)
Close on Nov 18, 2026Market cap $24.76BP/E 20.7Yield –
United Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
United Therapeutics's pe ratio was 21.3× on Nov 11, 2026, against 18.4× a year earlier. Over the last 5 years it ranged from 11.0× to 21.4×, with a median of 16.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 21.3× | +2.9 |
| 2025 | Dec 31, 2025 | 18.4× | +2.9 |
| 2024 | Dec 31, 2024 | 15.5× | +3.4 |
| 2023 | Dec 29, 2023 | 12.1× | −6.8 |
| 2022 | Dec 30, 2022 | 18.9× | +3.4 |
| 2021 | Jan 29, 2021 | 15.5× | +1.1 |
| 2020 | Dec 31, 2020 | 14.4× | +6.7 |
| 2019 | Apr 30, 2019 | 7.7× | −1.1 |
| 2018 | Dec 31, 2018 | 8.8× | −4.3 |
| 2017 | Dec 29, 2017 | 13.0× | +3.4 |
| 2016 | Dec 30, 2016 | 9.7× | −2.4 |
| 2015 | Dec 31, 2015 | 12.1× | −26.0 |
| 2014 | Dec 31, 2014 | 38.1× | +17.4 |
| 2013 | Dec 31, 2013 | 20.6× | +9.6 |
| 2012 | Dec 31, 2012 | 11.0× | −4.9 |
| 2011 | Dec 30, 2011 | 15.9× | – |
See a number that looks wrong?